Cargando…
GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies
BACKGROUND: Autoantibodies against the smaller isoform of glutamate decarboxylase (GAD65Ab) reflect autoimmune etiologies in Type 1 diabetes (T1D) and several neurological disorders, including Stiff Person Syndrome (SPS). GAD65Ab are also reported in cases of epilepsy, indicating an autoimmune compo...
Autores principales: | Liimatainen, Suvi, Honnorat, Jerome, Pittock, Sean J., McKeon, Andrew, Manto, Mario, Radtke, Jared R., Hampe, Christiane S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892043/ https://www.ncbi.nlm.nih.gov/pubmed/29636076 http://dx.doi.org/10.1186/s13023-018-0787-5 |
Ejemplares similares
-
Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013) -
Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
por: Wang, Xin, et al.
Publicado: (2012) -
Prevalence and Regional Distribution of Autoantibodies Against GAD65Ab in a European Population Without Diabetes: The EPIC-InterAct Study
por: Rolandsson, Olov, et al.
Publicado: (2015) -
GAD65 Antibody-Associated Epilepsy
por: Valinčiūtė, Justina, et al.
Publicado: (2023) -
GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
por: Maruyama, Taro, et al.
Publicado: (2008)